RT Journal Article
SR Electronic
T1 Novel Deep Learning Methodology for Automated Classification of Adamantinomatous Craniopharyngioma Using a Small Radiographic Dataset
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.16.20063057
DO 10.1101/2020.04.16.20063057
A1 Prince, Eric
A1 Whelan, Ros
A1 Mirsky, David M.
A1 Hankinson, Todd C.
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.16.20063057.abstract
AB Modern Deep Learning (DL) networks routinely achieve classification accuracy superior to human experts, leveraging scenarios with vast amounts of training data. Community focus has now seen a shift towards the design of accurate classifiers for scenarios with limited training data. Such an example is the uncommon pediatric brain tumor, Adamantinomatous Craniopharyngioma (ACP). Recent work has demonstrated the efficacy of Transfer Learning (TL) and novel loss functions for the training of DL networks in limited data scenarios. This work describes a DL approach utilizing TL and a state-of-the-art custom loss function for predicting ACP diagnosis from radiographic data, achieving performance (CT AUPR=0.99±0.01, MRI AUPR=0.99±0.02) superior to reported human performance (0.87).Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding to facilitate computational hardware was provided by the Morgan Adams Foundation for pediatric cancer research.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon reasonable request by contacting the Corresponding Author